Penserra Capital Management LLC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
Penserra Capital Management LLC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q2 2022$56,000
+5.7%
13,728
+24.6%
0.00%
+100.0%
Q1 2022$53,000
+82.8%
11,016
+613.0%
0.00%0.0%
Q3 2021$29,000
-40.8%
1,545
+0.7%
0.00%0.0%
Q2 2021$49,000
+8.9%
1,535
+1.3%
0.00%0.0%
Q1 2021$45,000
-31.8%
1,515
-1.3%
0.00%
-50.0%
Q4 2020$66,000
+120.0%
1,535
+171.2%
0.00%
+100.0%
Q3 2020$30,000
-71.7%
566
-67.7%
0.00%
-80.0%
Q2 2020$106,0001,7510.01%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders